LabCompass

Meng Bu

Neuroscience · The Ohio State University

Established · publishing since 1997

Publications

10

Citations

77

Est. group size

~1

Recurring co-author estimate

Active years

30

Publishing since 1997

Research summary
AI-generated

Meng Bu's available public record is very limited, with only a handful of recent items indexed, including a conference abstract on developing an oncolytic measles virus expressing MG53 as a potential lung cancer treatment. The listed OpenAlex topics (nerve injury/regeneration, immune responses, T-cell/B-cell immunology, stem cell research, retinal disorders) suggest a broad neuroscience and immunology background, but relevance scores are near zero, so these should be treated as tentative rather than confirmed specialties. Prospective students should note that the bibliographic data here is too sparse to draw firm conclusions about a defined research program.

Oncolytic virus therapy for cancerNerve injury and regenerationImmune system responses (T-cells, B-cells, interferons)Stem cell researchRetinal and eye disease research

Publication activity appears in the record only very recently (starting 2025-2026) with no indexed output over most of the prior decade, suggesting either a very new or an incompletely captured publication history rather than a clear long-term trend.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 0.8/year recently
17181920212223242025: 1 publication252026: 3 publications326
Publishes in
  • bioRxiv (Cold Spring Harbor Laboratory)×1
  • Cancer Research×1
  • Frontiers in Immunology×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile